메뉴 건너뛰기




Volumn 12, Issue 6, 2013, Pages 644-647

Cell therapy companies make strong progress from October 2012 to March 2013 amid mixed stock market sentiment

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOTECHNOLOGY; CELL THERAPY; DRUG INDUSTRY; EMBRYONIC STEM CELL; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; COMPARATIVE STUDY; ECONOMICS; INVESTMENT; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION;

EID: 84878836586     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2013.05.017     Document Type: Note
Times cited : (15)

References (9)
  • 1
    • 84874503213 scopus 로고    scopus 로고
    • 282-282
    • M. Baker Nature 493 2013 282-282
    • (2013) Nature , vol.493
    • Baker, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.